Connect with others who understand.

sign up log in
About MyLymphomaTeam

List of Treatments for Lymphoma

Below is a listing of treatments and therapies for lymphoma. Click on one to read more information or connect with others currently using it.

View:

Adcetris (Brentuximab vedotin)

Overview
Adcetris is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat several types of lymphoma in adults including classical Hodgkin lymphoma, anaplastic large cell lymphoma,… read more

Adriamycin (Doxorubicin)

Overview
Adriamycin, also known by its drug name doxorubicin, is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating Hodgkin lymphoma, non-Hodgkin lymphoma, and multiple… read more

Aliqopa (Copanlisib)

Overview
Aliqopa is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat relapsed follicular lymphoma. Aliqopa is indicated in cases where at least two previous therapies have been tried.… read more

Allogeneic (donor) stem cell transplant

Overview
Stem cell transplant after high-dose chemotherapy is sometimes used to treat people with lymphoma. The purpose of a stem cell transplant in lymphoma is to compensate for higher doses of chemotherapy that will… read more

Arranon (Nelarabine)

Overview
Arranon is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat T-cell lymphoblastic lymphoma and T-cell acute lymphoblastic leukemia. Arranon is indicated in cases where… read more

Arzerra (Ofatumumab)

Overview
Arzerra is a prescription drug approved by the Food and Drug Administration (FDA) to treat small cell lymphocytic lymphoma/chronic lymphocytic leukemia (SLL/CLL). Arzerra is often prescribed in combination with… read more

Autologous (self) stem cell transplant

Overview
Stem cell transplant after high-dose chemotherapy is sometimes used to treat people with lymphoma. The purpose of a stem cell transplant in lymphoma is to compensate for higher doses of chemotherapy that will… read more

Beleodaq (Belinostat)

Overview
Beleodaq is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat peripheral T-cell lymphoma that has relapsed or failed to respond to other drugs. Beleodaq is also referred… read more

Bexxar (Tositumomab and iodine I 131 tositumomab)

Overview
Bexxar is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with CD20­-positive, relapsed or refractory, low-grade, follicular, or transformed non-Hodgkin's lymphoma… read more

BiCNU (Carmustine)

Overview
BiCNU, also known by its drug name, carmustine, is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating Hodgkin lymphoma, non-Hodgkin lymphoma, and multiple myeloma.… read more

Blenoxane (Bleomycin)

Overview
Blenoxane, also known by its drug name, Bleomycin, is a prescription medication approved by the Food and Drug Administration (FDA) for treating Hodgkin lymphoma and non-Hodgkin lymphoma (NHL). Blenoxane is… read more

Blood transfusion

Overview
Lymphoma treatments including chemotherapy and radiation therapy can destroy bone marrow, making it impossible produce new blood cells. In people with some types of lymphoma, cancer cells can damage the bone… read more

Breyanzi (lisocabtagene maraleucel)

Overview
Breyanzi is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsed or refractory large B-cell lymphoma who have been treated with at least two previous… read more

Brukinsa (Zanubrutinib)

Overview
Brukinsa is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with mantle cell lymphoma who have received at least one prior therapy. Brukinsa is also referred to by… read more

Calquence (Acalabrutinib)

Overview
Calquence is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with mantle cell lymphoma (MCL) who have received at least one prior treatment, or adults with chronic… read more

Chemotherapy

Overview
Chemotherapy is the treatment of cancer with drugs that destroy or slow the growth of cancer cells. Some doctors may refer to all medication prescribed for someone with lymphoma as chemotherapy. Chemotherapy is… read more

Clinical trials

Overview
Depending on several factors, you may be eligible to participate in clinical trials studying new treatments for lymphoma. Clinical trials are the only way that new treatments for lymphoma can be tested.… read more

Complementary and integrative therapies

Overview
In a survey of 700 people living with lymphoma, approximately 90 percent had used complementary or alternative treatments. Complementary treatments are those used alongside standard medical treatments… read more

Copiktra (Duvelisib)

Overview
Copiktra is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat non-Hodgkin lymphomas including small lymphocytic lymphoma (SLL), chronic lymphocytic leukemia (CLL), and… read more

Corticosteroids

Overview
Corticosteroids are a class of prescription drugs approved by the Food and Drug Administration (FDA) to treat inflammation. Corticosteroids are sometimes used to treat people with lymphoma.

The most common… read more

Cytoxan (Cyclophosphamide)

Overview
Cytoxan, also known by its drug name, Cyclophosphamide, is a prescription medication approved by the Food and Drug Administration (FDA) for treating cancers including Hodgkin lymphoma, non-Hodgkin lymphoma… read more

DepoCyt (Cytarabine liposome)

Overview
DepoCyt is a prescription medication approved by the Food and Drug Administration (FDA) to treat certain types of leukemia and lymphoma that have spread to the meninges – the layers of tissue that cover the… read more

DTIC-Dome (Dacarbazine)

Overview
DTIC-Dome, also known by its drug name, dacarbazine, is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating Hodgkin lymphoma. DTIC-Dome is often combined with other… read more

Erwinaze (Asparaginase Erwinia chrysanthemi)

Overview
Erwinaze is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with acute lymphoblastic leukemia (ALL) who have developed an allergy to E. coli-derived asparaginase.… read more

Erythropoietin (EPO)

Overview
Erythropoietin is a hormone that stimulates red blood cell production in the bone marrow. Erythropoietin is secreted by the kidneys.

Anemia (low levels of red blood cells) is common in people with lymphoma… read more

Exercise

Overview
Regular physical activity has been shown to benefit people with lymphoma in many ways. Most importantly, exercise has been proven to help those diagnosed with lymphoma live longer. Exercise can also improve the… read more

Flu and pneumonia vaccinations

Overview
People who currently have or have had lymphoma and other cancers are at greater risk for severe infections and serious complications from influenza (the flu) and pneumonia.

The U.S. Centers for Disease… read more

Folotyn (Pralatrexate)

Overview
Folotyn is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat peripheral T-cell lymphoma (PTCL) that has relapsed or failed to respond to other drugs. Folotyn is also… read more

Gazyva (Obinutuzumab)

Overview
Gazyva is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat follicular lymphoma and chronic lymphocytic leukemia. Gazyva is often prescribed in combination with other drugs… read more

Gleostine (Lomustine)

Overview
Gleostine is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat Hodgkin lymphoma that has progressed after initial therapy. Gleostine is often combined with a… read more

Imbruvica (Ibrutinib)

Overview
Imbruvica is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat several types of non-Hodgkin lymphoma, including mantle cell lymphoma, chronic lymphocytic leukemia (CLL)/small… read more

Interferon

Overview
Interferon is used to modify the immune system and slow the growth of cancer cells in people with hairy cell leukemia, cutaneous T-cell lymphoma, and aggressive follicular non-Hodgkin lymphoma (NHL). Interferon… read more

Intravenous immunoglobulin (IVIG)

Overview
In some cases of chronic lymphocytic leukemia (CLL) and lymphoma, abnormal versions of white blood cells known as plasma B cells proliferate, crowding out healthy cells and forming tumors. Healthy plasma cells… read more

Istodax (Romidepsin)

Overview
Istodax is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat cutaneous T-cell lymphoma and peripheral T-cell lymphoma (PTCL). Istodax is indicated in cases where at… read more

Keytruda (Pembrolizumab)

Overview
Keytruda is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat cancers including classic Hodgkin lymphoma and primary mediastinal B-cell lymphoma. Keytruda is indicated in… read more

Kymriah (Tisagenlecleucel)

Overview
Kymriah is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with large B-cell lymphoma. Kymriah is indicated when lymphoma is relapsed or refractory and at least two… read more

Leukeran (Chlorambucil)

Overview
Leukeran is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat Hodgkin lymphoma, chronic lymphocytic leukemia (CLL), lymphosarcoma, and giant follicular lymphoma.… read more

Matulane (Procarbazine)

Overview
Matulane is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat stage III and stage IV Hodgkin lymphoma. Matulane is part of the MOPP chemotherapy regimen in combination… read more

Medical marijuana

Overview
Medical marijuana, also known as medical cannabis, is widely used to treat chronic pain, nausea, vomiting, loss of appetite, and insomnia, all common symptoms of lymphoma or side effects of its treatment.… read more

Methotrexate

Overview
Methotrexate is a prescription drug approved by the Food and Drug Administration (FDA) to treat some types of cancer including non-Hodgkin lymphoma (NHL). Methotrexate is sold under brand names including… read more

Monjuvi (Tafasitamab-cxix)

Overview
Monjuvi is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with refractory or relapsed diffuse large B-cell lymphoma (DLBCL) not otherwise specified in people who are… read more

Mozobil (Plerixafor)

Overview
Mozobil is a prescription drug approved by the U.S. Food and Drug Administration (FDA) for use before autologous stem cell transplant in people with non-Hodgkin lymphoma and multiple myeloma. Mozobil is used in… read more

Mustargen (Mechlorethamine)

Overview
Mustargen is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat Hodgkin lymphoma in stages III and IV, chronic lymphocytic leukemia (CLL), mycosis fungoides,… read more

Neulasta (Pegfilgrastim)

Overview
Neulasta is a prescription drug approved by the Food and Drug Administration (FDA) to lower the risk of developing infections after receiving chemotherapy or some types of radiation. Neulasta is also known by… read more

Nutrition

Overview
Everyone feels their best when they consistently eat a healthy, balanced diet. For people with lymphoma, good nutrition can help you recover from treatment, reduce treatment side effects, support bone health,… read more

Oncovin (Vincristine)

Overview
Oncovin is a prescription medication used to treat several types of cancer including Hodgkin lymphoma, non-Hodgkin lymphoma, multiple myeloma, and chronic leukemias. Oncovin is often combined with other drugs… read more

Ontak (Denileukin diftitox)

Overview
Ontak is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat certain adults with persistent or recurrent cutaneous T-cell lymphoma. Ontak is also referred to by its drug name,… read more

Opdivo (Nivolumab)

Overview
Opdivo is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat cancers including classic Hodgkin lymphoma. Opdivo is indicated in cases where lymphoma has relapsed or progressed… read more

Plasmapheresis (Plasma exchange)

Overview
In some types of lymphoma – lymphoplasmacytic lymphoma, also known as Waldenström macroglobulinaemia, and multiple myeloma – cancer cells can secrete abnormal proteins. When abnormal proteins accumulate, they… read more

Polivy (Polatuzumab vedotin-piiq)

Overview

Polivy is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsed or refractory diffuse large B-cell lymphoma not otherwise specified. Polivy is indicated for… read more

Poteligeo (Mogamulizumab-kpkc)

Overview
Poteligeo is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsed or refractory mycosis fungoides (MF) and adults with relapsed or refractory Sézary syndrome… read more

Radiation therapy

Overview
Radiation therapy (also called RT or radiotherapy) is used to treat Hodgkins lymphoma (HL) and non-Hodgkins lymphoma (NHL). Radiation therapy is more likely to be used in cases where lymphoma is limited to one… read more

Revlimid (Lenalidomide)

Overview
Revlimid is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat mantle cell lymphoma and multiple myeloma. Revlimid is often combined with other drugs such as a… read more

Rituxan (Rituximab)

Overview
Rituxan is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat non-Hodgkin lymphoma. Rituxan may be prescribed alone or in combination with other antilymphoma drugs. Rituxan may… read more

Rituxan Hycela (Rituximab/hyaluronidase human)

Overview
Rituxan Hycela is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat follicular lymphoma, diffuse large B-cell lymphoma (DLBCL), and chronic lymphocytic leukemia (CLL). Rituxan… read more

Tazverik (Tazemetostat)

Overview
Tazverik is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat follicular lymphoma in adults and children 16 years and older whose tumors are positive for the EZH2 mutation and… read more

Tecartus (Brexucabtagene autoleucel)

Overview

Tecartus is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat relapsed or refractory mantle cell lymphoma (MCL) in adults. Tecartus is only available through a… read more

Thalomid (Thalidomide)

Overview
Thalomid, also known by its drug name, Thalidomide, is a prescription medication approved by the Food and Drug Administration (FDA) to treat multiple myeloma. Thalomid is sometimes prescribed off-label to treat… read more

Treanda (Bendamustine)

Overview
Treanda is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating chronic lymphocytic leukemia and indolent B-cell non-Hodgkin lymphoma. Treanda is sometimes prescribed… read more

Ukoniq (Umbralisib)

Overview
Ukoniq is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with follicular lymphoma who have received at least three previous therapies and adults with marginal zone… read more

Velcade (Bortezomib)

Overview
Velcade, also known by its drug name bortezomib, is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat mantle cell lymphoma and multiple myeloma. Velcade is often… read more

Venclexta (Venetoclax)

Overview
Venclexta is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and adults over 75 years old… read more

Vinblastine

Overview
Vinblastine is a prescription medication used to treat several types of cancer including Hodgkin lymphoma (stages III and IV), lymphocytic lymphoma, histiocytic lymphoma, and mycosis fungoides. Vinblastine is… read more

VP-16 (Etoposide)

Overview
VP-16, also known by its drug name, Etoposide, is a prescription medication used to treat several types of cancer including Hodgkin lymphoma and non-Hodgkin lymphoma. VP-16 is sometimes combined with other… read more

Xpovio (Selinexor)

Overview
Xpovio is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) who have been treated with at least two… read more

Yescarta (Axicabtagene ciloleucel)

Overview
Yescarta is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with large B-cell lymphoma. Yescarta is indicated when lymphoma is relapsed or refractory and at least two… read more

Zevalin (Ibritumomab tiuxetan)

Overview
Zevalin is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat non-Hodgkin lymphoma (NHL). Specifically, Zevalin is indicated for use in low-grade or follicular B-cell lymphoma… read more

Zolinza (Vorinostat)

Overview
Zolinza is a prescription medication approved by the Food and Drug Administration (FDA) to treat skin symptoms in people with cutaneous T-cell lymphoma (CTCL). Zolinza is indicated for use in cases where CTCL… read more

Zydelig (Idelalisib)

verview
Zydelig is a prescription drug approved by the Food and Drug Administration (FDA) to treat relapsed cases of follicular B-cell non-Hodgkin lymphoma, small lymphocytic lymphoma (SLL), and chronic lymphocytic… read more

Zynlonta (Loncastuximab tesirine-lpyl)

Overview
Zynlonta is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsed or refractory large B-cell lymphoma who have tried at least two other systemic treatments.… read more

Already a Member? Log in